Temat: "Urinary Bladder Neoplasms" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Optimal interval timing between transurethral resection of bladder tumors and Bacillus Calmette-Guerin perfusion.
Autorzy:: Cai TN; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Lu JL; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Chen Z; Department of Hepatobiliary Surgery II, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Liu ZH; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Liu ZW; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Yao K; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Qin ZK; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Ye YL; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (23), pp. 21279-21286. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: BCG Vaccine*/adverse effects
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Humans ; Retrospective Studies ; Transurethral Resection of Bladder ; Perfusion ; Neoplasm Recurrence, Local/pathology ; Neoplasm Invasiveness/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Granulomatous myocarditis arising from intravesical Bacillus Calmette-Guérin therapy leading to death diagnosed by postmortem examination: a case report.
Autorzy:: Geetha SD; Northwell Health, Department of Pathology, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, 2200 Northern Blvd, Suite 104, Greenvale, NY, 11548, USA. .
Chavarria HD; Northwell Health, Department of Pathology, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, 2200 Northern Blvd, Suite 104, Greenvale, NY, 11548, USA.
Abdelwahed M; Northwell Health, Department of Pathology, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, 2200 Northern Blvd, Suite 104, Greenvale, NY, 11548, USA.
Kataria N; Northwell Health, Department of Pathology, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, 2200 Northern Blvd, Suite 104, Greenvale, NY, 11548, USA.
Bijol V; Northwell Health, Department of Pathology, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, 2200 Northern Blvd, Suite 104, Greenvale, NY, 11548, USA.
Das K; Northwell Health, Department of Pathology, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, 2200 Northern Blvd, Suite 104, Greenvale, NY, 11548, USA.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2024 Jan 10; Vol. 18 (1), pp. 12. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: BCG Vaccine*/adverse effects
Carcinoma, Transitional Cell*/drug therapy
Myocarditis*/chemically induced
Urinary Bladder Neoplasms*/drug therapy
Aged ; Humans ; Male ; Autopsy ; Granuloma/chemically induced ; Fatal Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Mathematical modeling of BCG-based bladder cancer treatment using socio-demographics.
Autorzy:: Savchenko E; Department of Mathematics, Ariel University, Ariel, Israel.
Rosenfeld A; Department of Information Science, Bar Ilan University, Ramat-Gan, Israel.
Bunimovich-Mendrazitsky S; Department of Mathematics, Ariel University, Ariel, Israel. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Oct 31; Vol. 13 (1), pp. 18754. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: BCG Vaccine*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Humans ; Immunotherapy/methods ; Models, Theoretical ; Administration, Intravesical ; Demography ; Neoplasm Recurrence, Local/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Intratumoral PD1 T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer.
Autorzy:: Basak D; Division of Cancer Biology and Inflammatory Disorder, IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Mondal S; Department of Urology, IPGME&R and SSKM Hospital, Kolkata 700020, India.
Srivastava SK; Department of Urology, IPGME&R and SSKM Hospital, Kolkata 700020, India.
Sarkar D; Division of Cancer Biology and Inflammatory Disorder, IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India.
Sarkar I; Division of Cancer Biology and Inflammatory Disorder, IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Basu S; Division of Cancer Biology and Inflammatory Disorder, IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India.
Bhoumik A; Division of Cancer Biology and Inflammatory Disorder, IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India.
Chowdhury S; Division of Cancer Biology and Inflammatory Disorder, IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Pal DK; Department of Urology, IPGME&R and SSKM Hospital, Kolkata 700020, India.
Chatterjee S; Division of Cancer Biology and Inflammatory Disorder, IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.; Pokaż więcej
Źródło:: Cells [Cells] 2023 Jul 26; Vol. 12 (15). Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: BCG Vaccine*/therapeutic use
Non-Muscle Invasive Bladder Neoplasms*/drug therapy
Non-Muscle Invasive Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Humans ; CD8-Positive T-Lymphocytes/pathology ; Hepatitis A Virus Cellular Receptor 2 ; Immunotherapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Efficacy of recombinant Bacillus Calmette-Guérin containing dltA in in vivo three-dimensional bio-printed bladder cancer-on-a-chip and ex vivo orthotopic mouse model.
Autorzy:: Choi J; Department of Urology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea.
Jung TY; Department of Urology, VHS Medical Center, Seoul, Korea.
Kim JH; Department of Urology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea.
Maeng S; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Kang SJ; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Kim M; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Choi YW; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Choi SY; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Kim SH; Cellsmith Inc., Seoul, Korea.
Chang IH; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea. .; Pokaż więcej
Źródło:: Investigative and clinical urology [Investig Clin Urol] 2023 May; Vol. 64 (3), pp. 296-305.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: BCG Vaccine*/pharmacology
BCG Vaccine*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Mice ; Animals ; Recombinant Proteins/therapeutic use ; Cell Line, Tumor ; Lab-On-A-Chip Devices ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Clinical presentation of bacille Calmette-Guérin (BCG) infections after BCG instillation therapy.
Autorzy:: Nurminen P; Department of Urology, Turku University Hospital, University of Turku, Turku, Finland.
Ettala O; Department of Urology, Turku University Hospital, University of Turku, Turku, Finland.
Uusitalo-Seppälä R; Department of Infectious Diseases, Satakunta Hospital District, Pori, Finland.
Högerman M; Department of Mathematics and Statistics, University of Turku, Turku, Finland.
Kaipia A; Department of Urology, Tampere University Hospital, Tampere, Finland.
Boström PJ; Department of Urology, Turku University Hospital, University of Turku, Turku, Finland.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2023 Mar; Vol. 131 (3), pp. 306-312. Date of Electronic Publication: 2022 Aug 30.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: BCG Vaccine*/therapeutic use
Urinary Bladder Neoplasms*/therapy
Humans ; Administration, Intravesical

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Editorial Comment from Dr Ide to Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.
Autorzy:: Ide H; Department of Urology, Tokyo Saiseikai Central Hospital, Tokyo, Japan.; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2022 Oct; Vol. 29 (10), pp. 1203-1204. Date of Electronic Publication: 2022 Jul 20.
Typ publikacji:: Journal Article; Comment
MeSH Terms:: BCG Vaccine*/adverse effects
Mycobacterium bovis*
Urinary Bladder Neoplasms*/drug therapy
Adjuvants, Immunologic/therapeutic use ; Administration, Intravesical ; Humans ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/epidemiology ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Editorial Comment from Dr Leow et al. to Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guerin failure in non-muscle invasive bladder cancer.
Autorzy:: Leow JJ; Department of Urology, Tan Tock Seng Hospital, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Chen K; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Urology, Singapore General Hospital, Singapore.; Duke-NUS Medical School, Singapore.
Yuen JSP; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Urology, Singapore General Hospital, Singapore.; Duke-NUS Medical School, Singapore.; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2022 Oct; Vol. 29 (10), pp. 1205-1206. Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:: Journal Article; Comment
MeSH Terms:: BCG Vaccine*/adverse effects
Mycobacterium bovis*
Urinary Bladder Neoplasms*/drug therapy
Adjuvants, Immunologic/therapeutic use ; Administration, Intravesical ; Humans ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/epidemiology ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Editorial Comment from Dr Naselli and Dr Pirola to Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.
Autorzy:: Naselli A; Urology Department, San Giuseppe Hospital, IRCCS Multimedica, Multimedica Group, Milan, Italy.
Pirola GM; Urology Department, San Giuseppe Hospital, IRCCS Multimedica, Multimedica Group, Milan, Italy.; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2022 Oct; Vol. 29 (10), pp. 1204-1205. Date of Electronic Publication: 2022 Jul 20.
Typ publikacji:: Journal Article; Comment
MeSH Terms:: BCG Vaccine*/adverse effects
Mycobacterium bovis*
Urinary Bladder Neoplasms*/drug therapy
Adjuvants, Immunologic/therapeutic use ; Administration, Intravesical ; Humans ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/epidemiology ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Outcomes of bacillus Calmette-Guérin therapy without a maintenance schedule for high-risk non-muscle-invasive bladder cancer in the second transurethral resection era.
Autorzy:: Kikuchi H; Department of Urology, Hokkaido University Graduate School of Medicine, Japan.
Abe T; Department of Urology, Hokkaido University Graduate School of Medicine, Japan.
Matsumoto R; Department of Urology, Hokkaido University Graduate School of Medicine, Japan.
Osawa T; Department of Urology, Hokkaido University Graduate School of Medicine, Japan.
Maruyama S; Department of Urology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan.
Murai S; Department of Urology, Hokkaido University Graduate School of Medicine, Japan.
Shinohara N; Department of Urology, Hokkaido University Graduate School of Medicine, Japan.; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2022 Mar; Vol. 29 (3), pp. 251-258. Date of Electronic Publication: 2021 Dec 11.
Typ publikacji:: Journal Article
MeSH Terms:: BCG Vaccine*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Adjuvants, Immunologic/therapeutic use ; Administration, Intravesical ; Humans ; Neoplasm Invasiveness/pathology ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/prevention & control ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.
Autorzy:: Nishimura N; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
Miyake M; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
Iida K; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
Miyamoto T; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.
Tomida R; Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
Numakura K; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
Inokuchi J; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Yoneyama T; Department of Advanced Transplant and Regenerative Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Matsumura Y; Department of Urology, Nara Prefecture General Medical Center, Nara, Japan.
Yajima S; Division of Urology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Masuda H; Division of Urology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Terada N; Department of Urology, Miyazaki University, Miyazaki, Japan.
Taoka R; Department of Urology, Faculty of Medicine, Kagawa University, Takamatsu, Kagawa, Japan.
Kobayashi T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kojima T; Department of Urology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Matsui Y; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
Nishiyama N; Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan.
Kitamura H; Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan.
Nishiyama H; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Fujimoto K; Department of Urology, Nara Medical University, Kashihara, Nara, Japan.; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2022 Mar; Vol. 29 (3), pp. 242-249. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: BCG Vaccine*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/surgery
Adjuvants, Immunologic/therapeutic use ; Administration, Intravesical ; Cystectomy/methods ; Humans ; Japan/epidemiology ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/prevention & control ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Low-dose versus standard-dose bacille Calmette-Guérin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials.
Autorzy:: Choi SY; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea. .
Ha MS; Department of Urology, Hyundae General Hospital, Chung-Ang University College of Medicine, Namyangju, Korea.
Kim JH; Department of Urology, Hanil General Hospital, Seoul, Korea.
Chi BH; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Kim JW; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Chang IH; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Kim TH; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Myung SC; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.; Pokaż więcej
Źródło:: Investigative and clinical urology [Investig Clin Urol] 2022 Mar; Vol. 63 (2), pp. 140-150.
Typ publikacji:: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms:: BCG Vaccine*/adverse effects
Urinary Bladder Neoplasms*/drug therapy
Female ; Humans ; Male ; Randomized Controlled Trials as Topic

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Editorial Comment from Dr Sazuka to Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.
Autorzy:: Sazuka T; Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2022 Mar; Vol. 29 (3), pp. 249-250. Date of Electronic Publication: 2021 Dec 15.
Typ publikacji:: Editorial; Comment
MeSH Terms:: BCG Vaccine*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Administration, Intravesical ; Cystectomy ; Humans ; Japan/epidemiology

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Editorial Comment from Dr Shindo to Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.
Autorzy:: Shindo T; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2022 Mar; Vol. 29 (3), pp. 250. Date of Electronic Publication: 2022 Jan 04.
Typ publikacji:: Editorial; Comment
MeSH Terms:: BCG Vaccine*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Administration, Intravesical ; Cystectomy ; Humans ; Japan/epidemiology

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study.
Autorzy:: Murakami K; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Kamat AM; Department of Urology, UT MD Anderson Cancer Center, Houston, TX, USA.
Dai Y; Department of Epidemiology, University of Florida, Gainesville, FL, USA.
Pagano I; Cancer Prevention and Control Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Chen R; Department of Microbiology and Immunology, The State University of New York at Buffalo, Buffalo, NY, USA.
Sun Y; Department of Microbiology and Immunology, The State University of New York at Buffalo, Buffalo, NY, USA.; Department of Computer Science and Engineering, The State University of New York at Buffalo, Buffalo, NY, USA.; Department of Biostatistics, The State University of New York at Buffalo, Buffalo, NY, USA.
Gupta A; Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Goodison S; Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.
Rosser CJ; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Nonagen Bioscience Corp., Los Angeles, CA, USA.
Furuya H; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Pokaż więcej
Źródło:: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2022; Vol. 33 (1), pp. 151-157.
Typ publikacji:: Journal Article
MeSH Terms:: BCG Vaccine*/therapeutic use
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/drug therapy
Administration, Intravesical ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Pilot Projects ; Urinalysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.
Autorzy:: Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hensley PJ; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Brooks NA; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Matulay J; Department of Urology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Li R; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Nogueras Gonzalez GM; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Navai N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Grossman HB; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Matin SF; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dinney CPN; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2021 Nov; Vol. 128 (5), pp. 568-574. Date of Electronic Publication: 2021 Feb 15.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Adjuvants, Immunologic/*therapeutic use
BCG Vaccine/*therapeutic use
Carcinoma, Transitional Cell/*drug therapy
Carcinoma, Transitional Cell/*pathology
Kidney Neoplasms/*pathology
Neoplasm Recurrence, Local/*pathology
Neoplasms, Second Primary/*pathology
Ureteral Neoplasms/*pathology
Urinary Bladder Neoplasms/*drug therapy
Aged ; Carcinoma, Transitional Cell/secondary ; Carcinoma, Transitional Cell/surgery ; Disease Progression ; Female ; Humans ; Kidney Pelvis ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Risk Factors ; Time Factors ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/surgery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors.
Autorzy:: Sun K; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Wang D; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Wu G; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Ma J; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Wang T; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Wu J; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Wang J; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2021 Nov; Vol. 10 (21), pp. 7534-7541. Date of Electronic Publication: 2021 Sep 21.
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Acetanilides/*therapeutic use
BCG Vaccine/*adverse effects
Thiazoles/*therapeutic use
Urinary Bladder Neoplasms/*therapy
Urinary Bladder, Overactive/*drug therapy
Urological Agents/*therapeutic use
Acetanilides/adverse effects ; Aged ; Cystectomy/adverse effects ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Postoperative Complications/drug therapy ; Prospective Studies ; Thiazoles/adverse effects ; Urinary Bladder Neoplasms/surgery ; Urinary Bladder, Overactive/etiology ; Urological Agents/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic response.
Autorzy:: Hensley PJ; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Brooks N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Matulay J; Department of Urology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Li R; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Nogueras González GM; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Navai N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Grossman HB; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dinney CP; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2021 Nov; Vol. 128 (5), pp. 634-641. Date of Electronic Publication: 2021 May 05.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Adjuvants, Immunologic/*administration & dosage
Adjuvants, Immunologic/*adverse effects
BCG Vaccine/*administration & dosage
BCG Vaccine/*adverse effects
Urinary Bladder Neoplasms/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Progression-Free Survival ; Proportional Hazards Models ; Survival Rate ; Time Factors ; Urinary Bladder Neoplasms/surgery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Establishment of Three-Dimensional Bioprinted Bladder Cancer-on-a-Chip with a Microfluidic System Using Bacillus Calmette-Guérin.
Autorzy:: Kim JH; Department of Urology, Hanil General Hospital, 308 Uicheon-ro, Dobong-gu, Seoul 01450, Korea.
Lee S; School of Mechanical Engineering, College of Engineering, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea.
Kang SJ; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea.
Choi YW; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea.
Choi SY; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea.
Park JY; School of Mechanical Engineering, College of Engineering, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea.; Department of Intelligent Energy and Industry, Graduate School, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea.
Chang IH; Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Aug 18; Vol. 22 (16). Date of Electronic Publication: 2021 Aug 18.
Typ publikacji:: Journal Article
MeSH Terms:: Cell Movement*
Cell Proliferation*
BCG Vaccine/*administration & dosage
Bioprinting/*instrumentation
Cytokines/*metabolism
Lab-On-A-Chip Devices/*statistics & numerical data
Urinary Bladder Neoplasms/*drug therapy
Bioprinting/methods ; Humans ; Tumor Cells, Cultured ; Urinary Bladder Neoplasms/immunology ; Urinary Bladder Neoplasms/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin.
Autorzy:: Brooks NA; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kokorovic A; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xiao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Matulay JT; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Li R; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Ranasinghe WKB; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nagaraju S; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shen Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gao J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Navai N; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dinney CPN; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Grossman HB; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kamat AM; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2021 Jul; Vol. 128 (1), pp. 65-71. Date of Electronic Publication: 2020 Dec 05.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Body Mass Index*
Adjuvants, Immunologic/*therapeutic use
BCG Vaccine/*therapeutic use
Diabetes Complications/*complications
Obesity/*complications
Urinary Bladder Neoplasms/*complications
Urinary Bladder Neoplasms/*drug therapy
Aged ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Invasiveness ; Retrospective Studies ; Treatment Outcome ; Urinary Bladder Neoplasms/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Urinary Bladder Neoplasms"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język